Hemophilia Gene Therapy Market Share, Size, Trends & Analysis By Type, Region Insights, Key Players and Applications and Forecast to 2028

Report Summary

Eternity Insights has published a new study on Global Hemophilia Gene Therapy Market focusing on key segments as by Type (Hemophilia A,Hemophilia B, Other), by Application (Hemophilia A Gene Therapy,Hemophilia B Gene Therapy, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Hemophilia Gene Therapy Market.

The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.

Hemophilia Gene Therapy Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.

Global Hemophilia Gene Therapy Market Size, 2018-2028 (USD Million)

To learn more about this report

Request For Sample

Global Hemophilia Gene Therapy Market Segmentation:

Hemophilia Gene Therapy Market, By Type

• Hemophilia A
• Hemophilia B
• Other

Hemophilia Gene Therapy Market, By Application

• Hemophilia A Gene Therapy
• Hemophilia B Gene Therapy
• Other

To learn more about this report

Request For Sample

Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Hemophilia Gene Therapy market in terms of demand generation. The Hemophilia Gene Therapy market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Hemophilia Gene Therapy market for below listed coun-tries across each region.

North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).

Global Hemophilia Gene Therapy Market Taxonomy:

To learn more about this report

Request For Sample

Global Hemophilia Gene Therapy Market Competitive Landscape

The global Hemophilia Gene Therapy market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details

• Company Overview
• Financial Analysis
• Product Portfolio Analysis
• Strategic Overview
• SWOT Analysis

List of Companies Profiled in the report:

• Spark Therapeutics
• Ultragenyx
• Shire PLC
• Sangamo Therapeutics
• Bioverativ
• BioMarin
• uniQure
• Freeline Therapeutics
• Other Players of Specific Interest can be added based on requirement

Market Segmentation

Report Attributes	Details
The market size value in 2021	USD XX.XX Million
CAGR (2021 - 2028)	XX.XX %
The Revenue forecast in 2028	USD XX.XX Million
Base year for estimation	2021
Historical data	2018-2019
Forecast period	2022-2028
Quantitative units	Revenue in USD Million CAGR from 2021 to 2028
Report coverage	Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered	By Type Outlook, Application Outlook, Regional Outlook
By Type Outlook	Hemophilia A,Hemophilia B, Other
By Application Outlook	Hemophilia A Gene Therapy,Hemophilia B Gene Therapy, Other
Regional scope	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country scope	U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey
Key companies profiled	Spark Therapeutics,Ultragenyx,Shire PLC,Sangamo Therapeutics,Bioverativ,BioMarin,uniQure,Freeline Therapeutics
Customization Available	Yes, the report can be tailored to meet your specific requirements.

Key Benefits to the stake holders

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come

Table Of Contents

Table of Contents

Global Hemophilia Gene Therapy Market Report 2020, Forecast to 2027

1 Scope of the Study
1.1 Hemophilia Gene Therapy Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 Hemophilia Gene Therapy Industry Overview
2.1 Global Hemophilia Gene Therapy Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Hemophilia Gene Therapy Global Import Market Analysis
2.1.2 Hemophilia Gene Therapy Global Export Market Analysis
2.1.3 Hemophilia Gene Therapy Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Hemophilia A
2.2.2 Hemophilia B


2.3.2 Hemophilia B Gene Therapy


2.4.2 Global Hemophilia Gene Therapy Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Hemophilia Gene Therapy Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Hemophilia Gene Therapy Manufacturer Market Share
2.4.5 Top 10 Hemophilia Gene Therapy Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Hemophilia Gene Therapy Market
2.4.7 Key Manufacturers Hemophilia Gene Therapy Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Hemophilia Gene Therapy Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis

3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Hemophilia Gene Therapy Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers

4 Global Hemophilia Gene Therapy Market Size Categorized by Regions
4.1 Global Hemophilia Gene Therapy Revenue, Sales and Market Share by Regions
4.1.1 Global Hemophilia Gene Therapy Sales and Market Share by Regions (2015-2020)
4.1.2 Global Hemophilia Gene Therapy Revenue and Market Share by Regions (2015-2020)
4.2 Europe Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
4.3 APAC Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
4.4 North America Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
4.5 South America Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)

5 Europe Hemophilia Gene Therapy Market Size Categorized by Countries
5.1 Europe Hemophilia Gene Therapy Sales, Revenue and Market Share by Countries
5.1.1 Europe Hemophilia Gene Therapy Sales by Countries (2015-2020)
5.1.2 Europe Hemophilia Gene Therapy Revenue by Countries (2015-2020)
5.1.3 Germany Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
5.1.4 UK Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
5.1.5 France Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
5.1.6 Russia Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
5.1.7 Italy Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
5.1.8 Spain Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
5.2 Europe Hemophilia Gene Therapy Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Hemophilia Gene Therapy Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Hemophilia Gene Therapy Sales Market Share by Type (2015-2020)
5.3.2 Europe Hemophilia Gene Therapy Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Hemophilia Gene Therapy Sales Market Share by Application (2015-2020)

6 Asia-Pacific Hemophilia Gene Therapy Market Size Categorized by Countries
6.1 Asia-Pacific Hemophilia Gene Therapy Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Hemophilia Gene Therapy Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Hemophilia Gene Therapy Revenue by Countries (2015-2020)
6.1.3 China Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
6.1.4 Japan Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
6.1.5 Korea Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
6.1.6 India Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
6.1.8 Australia Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Hemophilia Gene Therapy Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Hemophilia Gene Therapy Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Hemophilia Gene Therapy Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Hemophilia Gene Therapy Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Hemophilia Gene Therapy Sales and Market Share by Application (2015-2020)

7 North America Hemophilia Gene Therapy Market Size Categorized by Countries
7.1 North America Hemophilia Gene Therapy Sales, Revenue and Market Share by Countries
7.1.1 North America Hemophilia Gene Therapy Sales by Countries (2015-2020)
7.1.2 North America Hemophilia Gene Therapy Revenue by Countries (2015-2020)
7.1.3 United States Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
7.1.4 Canada Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
7.1.5 Mexico Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
7.2 North America Hemophilia Gene Therapy Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Hemophilia Gene Therapy Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Hemophilia Gene Therapy Sales Market Share by Type (2015-2020)
7.3.2 North America Hemophilia Gene Therapy Revenue and Revenue Share by Type (2015-2020)
7.4 North America Hemophilia Gene Therapy Sales Market Share by Application (2015-2020)

8 South America Hemophilia Gene Therapy Market Size Categorized by Countries
8.1 South America Hemophilia Gene Therapy Sales, Revenue and Market Share by Countries
8.1.1 South America Hemophilia Gene Therapy Sales by Countries (2015-2020)
8.1.2 South America Hemophilia Gene Therapy Revenue by Countries (2015-2020)
8.1.3 Brazil Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
8.2 South America Hemophilia Gene Therapy Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Hemophilia Gene Therapy Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Hemophilia Gene Therapy Sales Market Share by Type (2015-2020)
8.3.2 South America Hemophilia Gene Therapy Revenue and Revenue Share by Type (2015-2020)
8.4 South America Hemophilia Gene Therapy Sales Market Share by Application (2015-2020)

9 Middle East and Africa Hemophilia Gene Therapy Market Size Categorized by Countries
9.1 Middle East and Africa Hemophilia Gene Therapy Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Hemophilia Gene Therapy Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Hemophilia Gene Therapy Revenue by Countries (2015-2020)
9.1.3 GCC Countries Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
9.1.4 Turkey Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
9.1.5 Egypt Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
9.1.6 South Africa Hemophilia Gene Therapy Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Hemophilia Gene Therapy Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Hemophilia Gene Therapy Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Hemophilia Gene Therapy Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Hemophilia Gene Therapy Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Hemophilia Gene Therapy Sales Market Share by Application (2015-2020)

10 Global Hemophilia Gene Therapy Market Segment by Type
10.1 Global Hemophilia Gene Therapy Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Hemophilia Gene Therapy Sales and Market Share by Type (2015-2020)
10.1.2 Global Hemophilia Gene Therapy Revenue and Market Share by Type (2015-2020)
10.2 Hemophilia A Sales Growth Rate and Price
10.2.1 Global Hemophilia A Sales Growth Rate (2015-2020)
10.2.2 Global Hemophilia A Price (2015-2020)
10.3 Hemophilia B Sales Growth Rate and Price
10.3.1 Global Hemophilia B Sales Growth Rate (2015-2020)
10.3.2 Global Hemophilia B Price (2015-2020)


11.1 Global Hemophilia Gene TherapySales Market Share by Application (2015-2020)
11.2 Hemophilia A Gene Therapy Sales Growth Rate (2015-2020)
11.3 Hemophilia B Gene Therapy Sales Growth Rate (2015-2020)


12.1 Global Hemophilia Gene Therapy Revenue, Sales and Growth Rate (2020-2027)
12.2 Hemophilia Gene Therapy Market Forecast by Regions (2020-2027)
12.2.1 Europe Hemophilia Gene Therapy Market Forecast (2020-2027)
12.2.2 APAC Hemophilia Gene Therapy Market Forecast (2020-2027)
12.2.3 North America Hemophilia Gene Therapy Market Forecast (2020-2027)
12.2.4 South America Hemophilia Gene Therapy Market Forecast (2020-2027)
12.2.5 Middle East & Africa Hemophilia Gene Therapy Market Forecast (2020-2027)
12.3 Hemophilia Gene Therapy Market Forecast by Type (2020-2027)
12.3.1 Global Hemophilia Gene Therapy Sales Forecast by Type (2020-2027)
12.3.2 Global Hemophilia Gene Therapy Market Share Forecast by Type (2020-2027)
12.4 Hemophilia Gene Therapy Market Forecast by Application (2020-2027)
12.4.1 Global Hemophilia Gene Therapy Sales Forecast by Application (2020-2027)
12.4.2 Global Hemophilia Gene Therapy Market Share Forecast by Application (2020-2027)

13 Analysis of Hemophilia Gene Therapy Industry Key Manufacturers
13.1 Spark Therapeutics
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Spark Therapeutics Hemophilia Gene Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Spark Therapeutics News
13.2 Ultragenyx
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Ultragenyx Hemophilia Gene Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Ultragenyx News
13.3 Shire PLC
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Shire PLC Hemophilia Gene Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Shire PLC News
13.4 Sangamo Therapeutics
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Sangamo Therapeutics Hemophilia Gene Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Sangamo Therapeutics News
13.5 Bioverativ
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Bioverativ Hemophilia Gene Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Bioverativ News
13.6 BioMarin
13.6.1 Company Details
13.6.2 Product Information
13.6.3 BioMarin Hemophilia Gene Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 BioMarin News
13.7 uniQure
13.7.1 Company Details
13.7.2 Product Information
13.7.3 uniQure Hemophilia Gene Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 uniQure News
13.8 Freeline Therapeutics
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Freeline Therapeutics Hemophilia Gene Therapy Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Freeline Therapeutics News



15 Appendix